Hernberg S, Kauppinen T, Riala R, Korkala M L, Asikainen U
Institute of Occupational Health, Helsinki, Finland.
Scand J Work Environ Health. 1988 Dec;14(6):356-65. doi: 10.5271/sjweh.1907.
An earlier case-referent study by the same authors [Int Arch Occup Environ Health 54 (1984) 147-153] reported that solvent-exposed women, but not men, had an increased risk for primary liver cancer. The present study was undertaken to verify these results. The relatives of deceased patients, ie, 377 liver cancer cases, 385 coronary infarction referents, and 476 stomach cancer referents, responded to a questionnaire on past employment and potentially relevant covariables, the response rates being 71.7, 72.7, and 69.0%, respectively. The information was assessed for solvent exposure by two occupational hygienists without knowledge of the patients' diagnoses. Seven male and seven female liver cancer cases had been exposed to solvents, the odds ratio being less than 1 for the men but greater than 3 for the women irrespective of the reference group used for comparison. The results confirm the authors' earlier findings. When both materials were combined, the odds ratio was 7.8 for the female liver cancer cases as compared with the infarction referents. In the combined material, nine female liver cancer cases, two stomach cancer referents, but no infarction referent had had at least probable exposure to chlorinated hydrocarbons. Such exposure was rare among all of the men in the study. This finding may explain why the increased liver cancer risk occurred only for the women, although a sex difference in sensitivity cannot be completely ruled out.
同一批作者早期进行的一项病例对照研究[《国际职业与环境卫生档案》54 (1984) 147 - 153]报告称,接触溶剂的女性而非男性患原发性肝癌的风险增加。本研究旨在验证这些结果。已故患者的亲属,即377例肝癌病例、385例冠状动脉梗死对照者和476例胃癌对照者,回答了一份关于过去职业和潜在相关协变量的问卷,答复率分别为71.7%、72.7%和69.0%。两名职业卫生学家在不知道患者诊断结果的情况下对溶剂接触信息进行了评估。7例男性和7例女性肝癌病例曾接触过溶剂,无论用于比较的参照组如何,男性的优势比小于1,而女性的优势比大于3。结果证实了作者早期的发现。当将两份资料合并时,与梗死对照者相比,女性肝癌病例的优势比为7.8。在合并资料中,9例女性肝癌病例、2例胃癌对照者,但没有梗死对照者曾至少有可能接触过氯代烃。这种接触在该研究的所有男性中很少见。这一发现可能解释了为何仅女性患肝癌的风险增加,尽管不能完全排除敏感性方面的性别差异。